Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Self-medication: Is regulation needed...from whom?].

C Caulin1, H Cranz

  • 1Service de Médecine Interne A, Hôpital Lariboisière, Paris, France.

Therapie
|December 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment.

Oncogene·2014
Same author

Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.

Oncogene·2011
Same author

Expression of intermediate filament proteins by normal and transformed mouse epidermal-keratinocytes in culture.

International journal of oncology·2011
Same author

[History of the evaluation of medicines aiming for marketing authorization].

Journal francais d'ophtalmologie·2008
Same author

[Age, an independent risk factor for thrombosis. Epidemiologic data].

Presse medicale (Paris, France : 1983)·2005
Same author

[What explains the increased rate of thromboses among the elderly? Pathophysiological data].

Presse medicale (Paris, France : 1983)·2005
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

French clinical pharmacology experts recommend a clear policy for self-medication products. This policy aims to develop safe self-care options while improving public health and aligning with EU standards.

Area of Science:

  • Pharmacology
  • Public Health Policy

Context:

  • The 1999 French Clinical Pharmacological meeting identified barriers to self-medication product development in France.
  • Despite public interest in health responsibility, regulatory hurdles have limited self-medication options.

Purpose:

  • To establish a consensus on a clear policy for self-medication products in France.
  • To outline key principles for developing and regulating self-medication drugs.

Summary:

  • A consensual definition of self-medication drugs was proposed, emphasizing pharmacist involvement and marketing authorization.
  • Key principles include authorized advertising, safe use through clear indications and information, simplified approval procedures, and pharmacist oversight.
  • Consideration of 'grey zone drugs' and alignment with EU requirements are crucial for a dynamic policy.

Related Experiment Videos

Impact:

  • Facilitates the development of self-medication products in France.
  • Enhances public health by promoting safe and responsible self-care.
  • Establishes a framework for a clear and dynamic self-medication policy compliant with EU regulations.